We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Abnormal Cell Responses and Cancer Progression

Life In Science   May 23, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Abnormal Cell Responses and Cancer Progression
 
 
 

RELATED LIFE IN SCIENCE

An Interview With CRISPR Pioneer Jennifer A. Doudna

Life In Science

In this interview, award-winning scientist Jennifer A. Doudna PhD – renowned for her fundamental work and leadership in developing CRISPR-mediated genome editing – touches on her current research focus, her greatest professional achievements and discusses what can be done to encourage more women to get involved in science.

READ MORE

Developing FTICR Mass Spectrometry Instruments with Unique Capabilities

Life In Science

Here Prof. Peter B. O'Connor, University of Warwick, touches on the adaptability of mass spectrometry, enabling researchers to study cancer, neurological disease, petroleum, and biopharmaceuticals.

READ MORE

Transforming Drug Discovery by Accelerating the Development of More Effective Therapies

Life In Science

John Baldoni currently heads up a drug discovery unit at GlaxoSmithKline. Since joining GSK in 1989, John has held numerous positions within the company and
has led many significant cross-functional strategic initiatives. The recently established Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, was conceived by John, with a mission “to accelerate the development of more effective therapies for patients”

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE